Press Releases AREV Life Sciences Global Corp.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 12:06:40 2023-07-11 pm EDT			5-day change	1st Jan Change
0.09 ^CAD	-10.00%		-.--%	-.--%

2023	AREV Life Sciences Global Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	AREV Life Sciences Global Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

AREV Announces Significant Corporate Progress Amid Trading Suspension	Feb. 06	AQ
CSE Bulletin: Suspensions (AREV, EMER)	23-07-20	NE
Canadian Investment Regulatory Organization Trading Halt - AREV	23-07-20	AQ
Notice Of Default - Update	23-07-10	AQ
Notice of Default - Update	23-05-15	AQ
AREV Implements AI as a Driving Force to Identify Science Backed Compounds Synergistic to its Proprietary Extracts to Increase Efficacy of Traditional Medicine	23-05-09	AQ
AREV Life Sciences Global Corp. Announces Filing of Application for Management Cease Trade Order	23-04-27	AQ
AREV Terminates Private Placement and Term Sheet with Fiberlab, Inc.	23-03-27	AQ
AREV Signs Term Sheet with Fiberlab, Inc.	23-03-15	AQ
AREV Life Sciences Provides Annual Review for 2022 and Operational Update	23-02-28	AQ
Team from Queensland Brain Institute Identifies New Hericerin Derivitives from Lions Mane that Boost Nerve Growth and Enhances Memory	23-02-15	AQ
Arev Issues Incentive Stock Options	23-01-16	AQ
Arev Board Change	23-01-09	AQ
AREV Annual General Meeting Results	23-01-04	AQ
AREV Issues Shares for Debt	22-11-09	AQ
AREV's Issues Shares for Debt	22-11-08	AQ
Dr. Andrew Levinson Joins AREV Life Sciences Global Corporation Scientific Advisory Board	22-10-28	AQ
AREV Notes U.S. Governments $2.9 Billion Assistance to Address Food Insecurity	22-09-22	AQ
SUSTAINN, AREV's Ready to Use Therapeutic Foods discussed in leading article in HealthHIV	22-08-25	AQ
AREV Adds Dr. Apte to the SAB	22-08-17	AQ

No results for this search